Home » Authors » Nuala Moran

Articles by Nuala Moran

Ardana Reports Positive Data In Teverelix LA Phase IIa Trial

June 1, 2005

Animal Testing Ethics Report Reaches No Solid Solution

June 1, 2005

Animal Testing Ethics Report Reaches No Solid Solution

June 1, 2005

Prolysis Gets $9.9M, Aims For Clinic By End Of 2006

June 1, 2005

Ardana Reports Positive Data In Teverelix LA Phase IIa Trial

June 1, 2005

Moving Fast, Astex Cleared For Clinical Trial Of AT 7519

May 25, 2005

ProStrakan Wants £50M IPO In Tough UK Public Market

May 25, 2005

Oxagen Brings In $59.8M; U.S. Firm As Lead Investor

May 25, 2005

Oxagen Brings In $59.8M; U.S. Firm As Lead Investor

May 25, 2005

ProStrakan Wants £50M IPO In Tough UK Public Market

May 25, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...